These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 36368769)

  • 21. Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders.
    Leuzy A; Smith R; Ossenkoppele R; Santillo A; Borroni E; Klein G; Ohlsson T; Jögi J; Palmqvist S; Mattsson-Carlgren N; Strandberg O; Stomrud E; Hansson O
    JAMA Neurol; 2020 Aug; 77(8):955-965. PubMed ID: 32391858
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.
    Lee SH; Cho H; Choi JY; Lee JH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2018 Feb; 33(2):262-272. PubMed ID: 29168583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in
    Wu L; Liu FT; Ge JJ; Zhao J; Tang YL; Yu WB; Yu H; Anderson T; Zuo CT; Chen L; Wang J
    Hum Brain Mapp; 2018 Dec; 39(12):4652-4662. PubMed ID: 29999569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease: A Head-to-Head Comparison Against Amyloid Positron Emission Tomography and Magnetic Resonance Imaging.
    Ossenkoppele R; Smith R; Mattsson-Carlgren N; Groot C; Leuzy A; Strandberg O; Palmqvist S; Olsson T; Jögi J; Stormrud E; Cho H; Ryu YH; Choi JY; Boxer AL; Gorno-Tempini ML; Miller BL; Soleimani-Meigooni D; Iaccarino L; La Joie R; Baker S; Borroni E; Klein G; Pontecorvo MJ; Devous MD; Jagust WJ; Lyoo CH; Rabinovici GD; Hansson O
    JAMA Neurol; 2021 Aug; 78(8):961-971. PubMed ID: 34180956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.
    Petrou M; Dwamena BA; Foerster BR; MacEachern MP; Bohnen NI; Müller ML; Albin RL; Frey KA
    Mov Disord; 2015 Jun; 30(7):928-35. PubMed ID: 25879534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subcortical
    Cho H; Choi JY; Hwang MS; Lee SH; Ryu YH; Lee MS; Lyoo CH
    Mov Disord; 2017 Jan; 32(1):134-140. PubMed ID: 27813160
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In Vivo Assessment of Tau Deposition in Alzheimer Disease and Assessing Its Relationship to Regional Brain Glucose Metabolism and Cognition.
    Baghel V; Tripathi M; Parida G; Gupta R; Yadav S; Kumar P; Dey AB; Damle NA; Kumar R; Bal C
    Clin Nucl Med; 2019 Nov; 44(11):e597-e601. PubMed ID: 31584490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging amyloid in Parkinson's disease dementia and dementia with Lewy bodies with positron emission tomography.
    Brooks DJ
    Mov Disord; 2009; 24 Suppl 2():S742-7. PubMed ID: 19877240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351.
    Oh M; Oh SJ; Lee SJ; Oh JS; Roh JH; Chung SJ; Lee JH; Lee CS; Kim JS
    Clin Nucl Med; 2020 Nov; 45(11):841-847. PubMed ID: 32910050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography.
    Edison P; Rowe CC; Rinne JO; Ng S; Ahmed I; Kemppainen N; Villemagne VL; O'Keefe G; Någren K; Chaudhury KR; Masters CL; Brooks DJ
    J Neurol Neurosurg Psychiatry; 2008 Dec; 79(12):1331-8. PubMed ID: 18653550
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vivo Tau Burden Is Associated with Abnormal Brain Functional Connectivity in Alzheimer's Disease: A
    Ju Z; Li Z; Lu J; Jiao F; Lin H; Bao W; Li M; Wu P; Guan Y; Zhao Q; Zhang H; Jiang J; Zuo C
    Brain Sci; 2022 Oct; 12(10):. PubMed ID: 36291289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers.
    Smith R; Puschmann A; Schöll M; Ohlsson T; van Swieten J; Honer M; Englund E; Hansson O
    Brain; 2016 Sep; 139(Pt 9):2372-9. PubMed ID: 27357347
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo amyloid imaging in autopsy-confirmed Parkinson disease with dementia.
    Burack MA; Hartlein J; Flores HP; Taylor-Reinwald L; Perlmutter JS; Cairns NJ
    Neurology; 2010 Jan; 74(1):77-84. PubMed ID: 20038776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.
    Burton EJ; McKeith IG; Burn DJ; Williams ED; O'Brien JT
    Brain; 2004 Apr; 127(Pt 4):791-800. PubMed ID: 14749292
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease.
    Garcia-Garcia D; Clavero P; Gasca Salas C; Lamet I; Arbizu J; Gonzalez-Redondo R; Obeso JA; Rodriguez-Oroz MC
    Eur J Nucl Med Mol Imaging; 2012 Nov; 39(11):1767-77. PubMed ID: 22872307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Hansen AK; Knudsen K; Lillethorup TP; Landau AM; Parbo P; Fedorova T; Audrain H; Bender D; Østergaard K; Brooks DJ; Borghammer P
    Brain; 2016 Jul; 139(Pt 7):2039-49. PubMed ID: 27190023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consistent Abnormalities in Metabolic Patterns of Lewy Body Dementias.
    Lu J; Ge J; Chen K; Sun Y; Liu F; Yu H; Xu Q; Li L; Ju Z; Lin H; Guan Y; Guo Q; Wang J; Zuo C; Wu P
    Mov Disord; 2022 Sep; 37(9):1861-1871. PubMed ID: 35857319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of cerebral glucose metabolism in Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies.
    Yong SW; Yoon JK; An YS; Lee PH
    Eur J Neurol; 2007 Dec; 14(12):1357-62. PubMed ID: 17941855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [
    Hong J; Lu J; Liu F; Wang M; Li X; Clement C; Lopes L; Brendel M; Rominger A; Yen TC; Guan Y; Tian M; Wang J; Zuo C; Shi K;
    EBioMedicine; 2023 Nov; 97():104835. PubMed ID: 37839135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid-Beta Positron Emission Tomography Imaging of Alzheimer's Pathology in Parkinson's Disease Dementia.
    Akhtar RS; Xie SX; Brennan L; Pontecorvo MJ; Hurtig HI; Trojanowski JQ; Weintraub D; Siderowf AD
    Mov Disord Clin Pract; 2016; 3(4):367-375. PubMed ID: 27500181
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.